Stay updated on Inhaled Imatinib for PAH Clinical Trial
Sign up to get notified when there's something new on the Inhaled Imatinib for PAH Clinical Trial page.
Latest updates to the Inhaled Imatinib for PAH Clinical Trial page
- Check4 days agoChange DetectedNo significant changes detected in core study content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%
- Check12 days agoChange DetectedNo additions or deletions detected. The page content appears unchanged with the same study details and status across screenshots.SummaryDifference0.1%
- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedPublication section wording changed to say that publications are automatically filled from PubMed, and the revision tag updated to v3.3.2.SummaryDifference0.0%
- Check33 days agoChange DetectedThe page no longer displays the government funding lapse notice describing potential delays and operation status; this was an administrative banner rather than study content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%
- Check40 days agoChange DetectedThe study page now shows a Terminated status, indicating the IMPAHCT trial is no longer recruiting.SummaryDifference0.0%
- Check48 days agoChange DetectedSeveral external health information links were removed from the ClinicalTrials.gov record, including MedlinePlus Genetics, GARD, PubMed entries, and government resource pages. These deletions remove quick access to background information and official resources but do not alter the study's reported design, endpoints, or eligibility criteria. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%
Stay in the know with updates to Inhaled Imatinib for PAH Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Inhaled Imatinib for PAH Clinical Trial page.